MedTrace Logo

Associations Between Early Neonatal Neuroimaging, Hammersmith Infant Neurological Examination and General Movements

NCT05217186 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 63

Last updated 2022-02-01

No results posted yet for this study

Summary

High risk infant is defined as infant with a negative history of environmental and biological factors, which can lead to neuromotor development problems. It is a heterogeneous group of premature infants born under thirty-seven weeks of age, with infants with low birth weight, term or developmental retardation for various reasons. Therefore, preterm infants with low birth weight can survive with a neurological sequelae such as cerebral palsy (CP), epilepsy, hearing and vision loss, mental retardation, speech and speech problems, and learning difficulties. The clinical diagnosis of CP, which can be observed in high-risk infants, is based on the combination of some neuroimaging and neurological examinations and assesments like neonatal imaging, general movements (GMs) and Hammersmith Infant Neurological Examination (HINE).

Conditions

  • Cerebral Palsy
  • Infant, Premature, Diseases
  • Infant Development
  • Neurologic Disorder
  • Development Delay
  • Infant Asphyxia
  • Infant, Small for Gestational Age
  • Infant, Newborn, Disease
  • Infant, Very Low Birth Weight

Interventions

DIAGNOSTIC_TEST

Measurements

All infants wirth high risk of cp will be assessed by neuroimaging and Hammersmith Neonatal Neurological Examination (HNNE) at term age, Prechtl's General movements (GMs) assessments form birth up to 3-5 months, and will be assesed by Hammersmith Infant Neurological Examination (HINE) at 2,3,6,9 and 12th months, also BAYLEY-III Infant and Toddler Development Assessment Scale (BAYLEY-III) at the 3rd, 6th, and 12th months.

Sponsors & Collaborators

  • Kahramanmaras Sutcu Imam University

    lead OTHER

Principal Investigators

  • hatice adıgüzel, PhD · Kahramanmaras Sutcu Imam University

Eligibility

Min Age
25 Weeks
Max Age
42 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-15
Primary Completion
2021-09-30
Completion
2021-10-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05217186 on ClinicalTrials.gov